Compass Therapeutics (CMPX) Current Assets (2018 - 2026)
Compass Therapeutics (CMPX) posted Current Assets of $195.7 million for Q1 2026, down 6.74% sequentially from $209.8 million in Q4 2025, and up 57.63% YoY from $124.1 million in Q1 2025.
Compass Therapeutics (CMPX) Current Assets (2018 - 2026) Analysis & Trends
Compass Therapeutics has reported Current Assets for 9 years, with the latest figure at $195.7 million in Q1 2026.
- Quarterly Current Assets rose 57.63% year-over-year to $195.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $195.7 million (up 57.63% YoY) and the FY2025 annual result came in at $209.8 million, up 58.05% from the prior year.
- Current Assets slipped to $195.7 million in Q1 2026 per CMPX's latest filing, from $209.8 million in the prior quarter.
- Over five years, Current Assets peaked at $221.1 million in Q3 2025 and troughed at $106.2 million in Q2 2025.
- A 5-year average of $159.7 million and a median of $153.9 million in 2023 frame the typical range for Current Assets.
- The sharpest annual moves came in 2022 and 2025: Current Assets surged 328.93% in 2022, then sank 30.84% in 2025.
- Over 5 years, Current Assets stood at $194.8 million in 2022, then retreated by 21.0% to $153.9 million in 2023, then dropped by 13.73% to $132.8 million in 2024, then soared by 58.05% to $209.8 million in 2025, then declined by 6.74% to $195.7 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $195.7 million, $209.8 million, and $221.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Compass Therapeutics | 405.20 Mn | 405.20 Mn | - | 180.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 180.89 Mn |
| Mar 31, 2026 | 195.69 Mn |
| Dec 31, 2025 | 209.82 Mn |
| Sep 30, 2025 | 221.12 Mn |
| Jun 30, 2025 | 106.20 Mn |
| Mar 31, 2025 | 124.15 Mn |
| Dec 31, 2024 | 132.75 Mn |
| Sep 30, 2024 | 141.14 Mn |
| Jun 30, 2024 | 153.55 Mn |
| Mar 31, 2024 | 158.61 Mn |
| Dec 31, 2023 | 153.88 Mn |
| Sep 30, 2023 | 166.58 Mn |
| Jun 30, 2023 | 175.27 Mn |
| Mar 31, 2023 | 183.60 Mn |
| Dec 31, 2022 | 194.79 Mn |
| Sep 30, 2022 | 122.55 Mn |
| Jun 30, 2022 | 134.55 Mn |
| Mar 31, 2022 | 140.28 Mn |
| Dec 31, 2021 | 147.11 Mn |
| Sep 30, 2021 | 28.57 Mn |